About Longevity Ranked and Iacob Pastina

Longevity Ranked is an independent, US-focused comparison publication by Iacob Pastina in The Compound Group portfolio. It helps readers check current NAD+ and sermorelin care offers before choosing a provider or paying.

• Publication: Longevity Ranked, published at longevityranked.com.
• Publisher and editor: Iacob Pastina, independent researcher and publisher. He is not a medical professional; the publication does not claim doctor, pharmacist or medical-board review.
• Portfolio: The Compound Group. GLP-1 Picks and HRT Picks are separate specialist publications, not interchangeable treatment guides.
• Scope: exact products and routes, advertised prices, payment schedules, care and pharmacy disclosures, policy terms and bounded evidence. Comparisons do not establish clinical superiority or lifespan extension.
• Funding and accountability: qualifying referrals may earn a commission. That relationship does not determine factual findings, objective order or public-information scores. Read the commercial disclosure and source-use rules.
• Contact and corrections: thecompoundgroupco@gmail.com. The corrections page explains what supporting source to include. This is an editorial inbox, not a clinical service.

Longevity is the market and reader interest; it is not a molecule. NAD+ is a coenzyme, while sermorelin is a peptide. They are covered in separate guides and comparisons so a broad brand does not erase those differences. Inclusion is not a claim that a product extends life. See the distinction.

Iacob Pastina is the independent researcher and publisher responsible for Longevity Ranked's editorial direction. AI tools assist with research, drafting and site maintenance. That assistance does not establish clinical review or verify a source claim; the original evidence and its limitations remain the basis for a finding. Longevity Ranked is independently operated, with no pharmaceutical or telehealth parent company.

Iacob is not a medical professional. These pages are source-based editorial comparisons; they do not imply that a doctor, pharmacist or medical-review board has reviewed or endorsed them. See his LinkedIn and GitHub, or contact thecompoundgroupco@gmail.com. The methodology explains what was verified and what was not.

They are separate publications in the same portfolio, with their own specialist reader journeys. GLP-1 Picks focuses on weight-management care. HRT Picks covers hormone care, including its HRT and TRT paths. Shared ownership does not make the treatments interchangeable or transfer an affiliate approval between websites.

See The Compound for the portfolio.

Do not use these comparisons to self-prescribe, choose a dose, combine treatments or replace medical care. Prices are not personal quotes and a provider listing is not an unconditional endorsement. For a symptom, adverse reaction, prescription or urgent concern, use an appropriate clinical service rather than this publication's inbox.